BRIEF-Eiger Biopharmaceuticals reports Q3 loss per share $1.49
November 08, 2016 at 08:09 AM EST
* As of sept 30, 2016, co had cash and cash equivalents of $56.3 million, compared to $4.8 million at december 31, 2015
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|